key: cord-0800727-ai7ryfb8
authors: Grégoire, Claude; Chasson, Lionel; Luci, Carmelo; Tomasello, Elena; Geissmann, Frédéric; Vivier, Eric; Walzer, Thierry
title: The trafficking of natural killer cells
date: 2007-10-30
journal: Immunol Rev
DOI: 10.1111/j.1600-065x.2007.00563.x
sha: 6ad4270ba8d6cb0a99b405c33635ac153470f7c2
doc_id: 800727
cord_uid: ai7ryfb8

Summary: Natural killer (NK) cells are large granular lymphocytes of the innate immune system that participate in the early control of microbial infections and cancer. NK cells can induce the death of autologous cells undergoing various forms of stress, recognizing and providing non‐microbial ‘danger’ signals to the immune system. NK cells are widely distributed in lymphoid and non‐lymphoid organs. NK cell precursors originate from the bone marrow and go through a complex maturation process that leads to the acquisition of their effector functions, to changes in their expression of integrins and chemotactic receptors, and to their redistribution from the bone marrow and lymph nodes to blood, spleen, liver, and lung. Here, we describe the tissue localization of NK cells, using NKp46 as an NK cell marker, and review the current knowledge on the mechanisms that govern their trafficking in humans and in mice.

Natural killer (NK) cells are lymphocytes of the innate immune system that can induce the death of allogeneic cells and autologous cells undergoing various forms of stress, such as upon microbial infection and malignant transformation (1, 2) . NK cells express an array of activating and inhibitory receptors, whose engagement allows them to discriminate between target and non-target cells (3) (4) (5) . The repertoire of NK cell receptors complements that of other innate sensors, such as scavanger receptors, Toll-like receptors (TLRs) or nucleotide oligomerization domain (NOD) proteins. The strategies of NK cell recognition thus broaden the detection of pathogenic situations where microbial 'danger signals' are missing in vivo, such as in the case of poorly immunogenic tumors.

Consistent with their role in immune surveillance, NK cells are widely distributed in the body. It is unclear, however, whether this wide distribution is due to their recirculation, due to the existence of NK subsets with different homing capacities, or due to their development at multiples sites. NK cells can also be recruited in various tissues upon inflammation. However, in contrast to B and T cells, the mechanisms governing NK cell trafficking remain poorly dissected.

It has been long appreciated that NK cells are widely distributed in mammals (6) . However, few studies have precisely addressed this distribution. An early study in rat showed that the frequency of large granular lymphocytes (LGLs), including NK and T-cell subsets, was high in the lung and peripheral blood, superior to that in the spleen, peritoneal exudates, and lymph nodes.

LGLs were also found to be absent in the thymus and bone marrow (7) . Subsequent studies in the mouse have shown the presence of NK cells, defined as NK1.1 1 CD3 À or DX5 1 CD3 À by flow cytometry, in various organs but never focused on their distribution (8) . We revisited this question and measured the percentage and number of mouse NK cells in various organs. Our results confirmed the wide distribution of NK cells in lymphoid and non-lymphoid organs (Fig. 1) . The frequency of NK cells in lymphocytes was found to be the highest in non-lymphoid organs such as the lung and liver. A similar phenomenon has also been observed for effector memory CD8 1 T cells (9) , suggesting similar mechanisms of trafficking for these two cell types and the existence of a niche for interleukin-15 (IL-15)dependent lymphocytes in non-lymphoid organs. The order for NK cell frequency is lung 4 liver 4 peripheral blood mononuclear cells (PBMCs) 4 spleen 4 bone marrow (BM) 4 lymph node (LN) 4 thymus, where NK cells are almost undetectable. For comparison, NK1.1 1 T cells predominate in the liver, while T cells prevail in blood and LN (Fig. 1) . Human NK cells also appear to be frequent in non-lymphoid organs (10, 11) .

The largest number of mouse NK cells, 2-3 million, can be found in the spleen. Significant reservoirs of NK cells may also be found in all other organs tested excluding the thymus (Fig. 1) . In humans, it was found that lymph node NK cells outnumber blood NK cells by 10:1 (12) , whereas an estimated 1:1 ratio was observed in the mouse. The reason for this discrepancy could be linked to the expression of CCR7 on a subset of human but not on mouse NK cells, as discussed later.

The presence of NK cells in epithelial tissues has been poorly investigated. NK cell numbers are massively increased in the uterus during pregnancy both in humans and mice (13) . In humans, CD3 -CD56 1 NK cells have been detected in the skin of healthy donors (14) and in the lymph draining this tissue (15) . An infiltration of NK cells has been reported in lesional atopic dermatitis skin, in both epidermis and dermis, after Malassezia exposure (16) , and in the inflammatory skin during the elicitation phase of contact hypersensitivity in a mouse model of allergic contact dermatitis (17) . Furthermore, several groups have reported an accumulation of cells expressing an NK cell phenotype in skin psoriatic lesions (18) (19) (20) . However, further investigations are required to clearly determine whether infiltrating cells are 'true' NK cells or rather NK-like T cells. In a normal human intestine, CD3 À intraepithelial leukocytes expressing NK cell markers such as CD122, CD161, CD2, CD94, CD56, or CD16 have been described (21) (22) (23) (24) . Finally, CD3 À NK1.1 1 cells have been recently identified in cell suspensions prepared from mouse vaginal tissue (25) . Moreover, IL-15 À / À and/or RAG2 À / À g c À / À mice are more sensitive to genital herpes simplex virus 2 (HSV-2) infection, suggesting a potential implication of NK cells in the control of infection spreading in mucosal tissues (26, 27) .

In situ visualization of NK cells has been hampered by the lack of specific reagents. Previous attempts to identify NK cells in situ were based on adoptive transfers of fluorescently labeled cells or staining with anti-NK1.1, anti-Ly49G2, or anti-CD49b (28) (29) (30) (31) (32) . However, none of the aforementioned antibodies are NK cell specific (NK1.1, CD49b) or expressed on all NK cells (Ly49G2, CD49b). We recently described that the cell surface expression of the activating NK cell receptor NKp46 (CD336) defines at best NK cells across mammalian species, providing the opportunity to look at NK cells in situ on tissue sections using anti-NKp46 antibodies (33) . In the spleen, NK cells are mostly found in the red pulp at a steady state, thus excluded from the T and B lymphocyte-rich area (defined by CD3 and CD19 staining) ( Fig. 2A) .

Staining for metallophilic macrophages [sialoadhesin (Sn)] (Fig. 2B ) and marginal zone macrophages (SignR1) (Fig. 2C) reveals that a few NK cells are also present in the marginal zone but do not go beyond this zone toward the white pulp. Antibodies to NKp46 and CD31 [platelet-endothelial cell adhesion molecule-1 (PECAM-1), an endothelial marker] stain the same regions, suggesting that most splenic NK cells are in fact located inside blood sinuses (Fig. 2D) . Occasional NKp46 1 cells are found in the white pulp, but staining for CD31 suggests that many of them are in fact located within sinuses or vessels (Fig. 2D ). Many other cell types can be found in the vicinity of the 'NK cell zone'. In particular, most CD11b high cells (including macrophages) (Fig. 2E) are found in the red pulp and the marginal zone, whereas many CD11c high cells (including dendritic cells) (Fig. 2F ) are found not only in the white pulp but also in the marginal zone and the red pulp. Cell-cell contacts between NK cells and macrophages (either of the red pulp or of the marginal zone) can be seen on these static images. These observations support the existence of interactions between NK cells and macrophages, as well as NK cells and dendritic cells. Such interactions have been extensively documented in vitro (34) (35) (36) (37) and lead to the mutual regulation of these different cell types in the orchestration of immune responses.

At a steady state, NK cells are also found in the peripheral LN, mostly excluded from T-and B-cell zones (33, authors' unpublished data), consistent with previous studies (29) . NK cells are found in perifollicular regions, in the paracortex, and especially in the medulla zone within lymphatic sinuses (29) . In the perifollicular region, NK cells are found again in sinuses surrounding the follicles and especially between these follicles, at the site where presumably dendritic cells migrating from tissues arrive to the draining LN through an afferent lymph (29) .

Within secondary lymphoid organs, the three types of lymphocytes (T, B, and NK cells) thus localize in distinct compartments. NK cells are preferentially found inside vessels or sinuses, either blood or lymphatics. The same conclusion could also be reached for the liver, as it is known that most hepatic lymphocytes are present in the sinusoids (38) and are absent from the parenchymal space.

Compelling evidence points to the BM as the primary site of NK cell development in adults at a steady state (6) . Moreover, recent articles suggested that LN and thymus could be alternative sources of NK cells (39, 40) . The relative contribution of these organs to the pool of NK cells is not known but is expected to be low at a steady state. Indeed, this extramedullary 'NK-poiesis' appears to produce phenotypically distinct NK cells, expressing the a chain of the IL-7 receptor (40) . Such NK cells make up o 5% of the total NK cells. Moreover, a careful examination of thymic NK cells reveals that many of them express CD3 intracellularly and share phenotypic and functional features with NK1.1 1 T cells, suggesting that they are in fact NK-like T cells (41) . However, in mice where Tcell development is blocked by genetic means, a very high number of NK cells develop in the thymus, showing the ability of T-cell precursors to develop into NK cells under particular conditions (40) . Furthermore, the normal liver contains a substantial number of immature NK cells, suggesting that NK cell precursors originating in the BM could seed the periphery and develop in situ (42) . Thus, it is possible that extramedullary NK cell development may take place under lymphopenic or other conditions that remain to be dissected.

Upon commitment to the NK cell lineage, NK cells go through a complex maturation process that leads to the gradual acquisition of effector functions. Three stages of NK cell maturation can be defined in the mouse based on the expression of CD11b and CD27: CD27 high CD11b dull (abbreviated as CD11b dull , the most immature), double-positive CD11b high CD27 high (abbreviated as DP), and CD11b high CD27 dull (abbreviated as CD27 dull , the most mature) (43) (44) (45) . DP and CD27 dull NK cells display stronger effector functions than CD11b dull NK cells (113) . The repartition of the three NK cell subsets varies with the tissue distribution. Whereas CD11b dull NK cells predominate in BM and LN, DP and especially CD27 dull NK cells prevail in the blood, liver, spleen, and lung (44) . As discussed later, the expression of different chemotactic receptors participates in the distinct homing capabilities of the NK cell subsets. In human, two subsets of NK cells have been described, CD56 dim and CD56 bright NK cells, that share many characteristics with CD11b dull and DP/CD27 dull NK cells, respectively (45) . This resemblance and other observations (12, 46) suggest that CD56 bright could be precursors of CD56 dim NK cells. Like their mouse counterparts, human CD56 bright NK cells are preferentially found in the LN, whereas CD56 dim cells are more abundant in the blood and spleen (12) . It is still unknown how and where NK cells complete their maturation. As the three NK cell subsets are found in all organs, it is likely that NK cell precursors or immature NK cells (CD11b dull stage) are seeded from the BM to the periphery, where they further develop in situ under the influence of microenvironmental factors.

Few data are available on the recirculation of NK cells between organs. Do NK cells traffic through peripheral organs? Do they exit lymphoid and non-lymphoid organs, or do they reside in tissues? An early study (47) showed that upon intravenous transfer into recipient rats, radiolabeled LGLs preferentially homed into the alveolar walls of the lung and the red pulp of the spleen.

LGLs were found, however, to be absent from the thoracic duct and LN (47) . Later, adoptive transfer experiments in mouse showed that splenic NK cells can home to the spleen, liver, and BM of recipient mice (48) (49) (50) . To gain an insight into NK cell trafficking, we performed an intravenous adoptive transfer of carboxyfluorescein succinimidyl ester (CFSE)labeled splenocytes into syngeneic, non-irradiated recipient mice. Twenty-four hours post-transfer, the percentage of NK cells within lymphocytes was measured in the blood, spleen, LN, BM, lung, and liver. The results showed that the distribution of transferred NK cells paralleled that of recipient NK cells (Fig.  3) , as did the distribution of NK1.1 1 T cells. Moreover, the relative proportion of NK cell subsets (CD11b dull to CD27 dull ) was similar between recipient and donor NK cells in every organ (data not shown). This simple experiment shows that (i) splenic NK cells are not programmed to home to the spleen but instead recirculate through all NK cell-containing organs and (ii) NK cell recirculation appears to be subset-specific: LN and BM are preferentially repopulated by CD11b dull NK cells and the blood, spleen and lung by CD27 dull NK cells.

The relative contribution of the factors that regulate tissue homing and egress, such as chemotactic receptors or homeostatic mechanisms, in the distribution of NK cells, remains to be addressed. Nevertheless, multiple approaches have been used to address the expression of chemotactic receptors in NK cells. First, several studies have measured the expression of chemotactic receptors on NK cells by flow cytometry, when antibodies were available (51) (52) (53) (54) (55) (56) (57) . Second, several strains of mice were created in which a green fluorescent protein cDNA was knocked in to genes encoding chemokine receptors (58, 59) . Using such mice, we found that CXCR6 is only expressed by a fraction of CD11b dull NK cells, whereas CX 3 CR1 is acquired with maturation, almost selectively expressed by CD27 dull NK cells (Fig. 4) .

Third, microarray experiments have been performed to measure gene expression at the pan-genomic level in human (60, 61) and mouse NK cell subsets ( Table 1) . The findings obtained with these different approaches reveal several trends (Fig. 5) .

First, a strong similarity in the expression pattern of chemokine receptors on human and mouse NK cell subsets emphasizes the homology between mouse CD11b dull NK cells and CD56 bright NK cells, on the one hand, and mouse DP/ CD27 dull and human CD56 dim NK cells on the other. There are, however, important differences. In particular, CCR7 is expressed by human CD56 bright NK cells, but no Ccr7 transcripts are detected in mouse CD11b dull NK cells. This difference might account for the distinct representation of NK cells in LN in humans (5% of lymphocytes) and in mice (0.5% of lymphocytes). Second, NK cells are poised to be rapidly recruited on sites of inflammation, as they express receptors for a broad range of inflammatory chemokines (CCR2, CCR5, CXCR3, CX 3 CR1). Third, the expression of chemotactic receptors switches over maturation in NK cells. In particular, CD27 dull /CD56 dim NK cells lose CXCR3 (and also CXCR4 in mouse) but acquire CX 3 CR1 (and also ChemR23 in human) expression, an array of receptors that are anticipated to influence their recirculation and their recruitment upon inflammation.

How do NK cells leave the bone marrow? A role for CXCR4 in human NK cell homing to the BM of reconstituted NOD (nonobese diabetic)/SCID (severe combined immunodeficient) mice was reported (62) , suggesting that loss of CXCR4 could contribute to the export of newly produced NK cells. However, CXCR4 seems to be uniformly expressed by NK cells from all organs. Moreover, a recent study showed that mouse treatment with a selective inhibitor of CXCR4 did not induce NK cell mobilization from the BM (63) . Another study showed that NK cells were virtually absent from the periphery of CXCR3 knockout mice (64) . However, three other studies did not report any defect in the distribution of NK cells in these mice (65-67), questioning the role of CXCR3 in the emigration of NK cells from BM. More recently, we found that NK cell maturation correlated with the acquisition of S1P 5 , one of the five sphingosine-phosphate (S1P) G-protein-coupled receptors (113) . S1P is a secreted lysophospholipid bound extensively to albumin and other plasma proteins. Coordinated activities of biosynthetic (sphingosine kinases) and biodegradative (sphingosine lyase and phosphatases) enzymes maintain S1P gradients in vivo, with high S1P concentrations in extracellular fluids and low S1P concentrations in tissues (68, 69) . In S1p 5 -deficient mice, a drastic decrease in peripheral NK cell counts is observed in the blood, spleen, and lung. This defective homing is NK cellintrinsic and correlates with an increased number of NK cells in the BM and LN. S1P 5 operates in NK cells as a chemotactic receptor for S1P in vitro, promoting NK cell homing in the blood, spleen, and lung in vivo. The extent of NK cell accumulation in BM and LN correlates with the level of S1P 5 expression (113) . Altogether, these observations suggest that S1P 5 provides an egress signal to NK cells, allowing both their export from the BM and their exit from LN (Fig. 6) . Interestingly, Id2 À / À E2a À / À mice have normal BM NK cells but very few mature NK cells in the spleen (70), prompting an investigation of whether these transcription factors control S1P 5 expression and/or function.

How do NK cells reach lymphoid organs? Like other lymphocytes, NK cells enter LNs through high endothelial venules (HEVs) and the spleen through the marginal sinus. CD56 bright human NK cells express L-selectin (CD62L) that allows interaction with glycosylated L-selectin ligands on HEVs (71) . CD62L is expressed at a similar level on mouse NK cell subsets isolated from the LN (44) and is required for mouse NK cell entry in LNs (72) (Fig. 6) . Whether CD62L is sufficient for the entry is not known. As discussed previously, most mouse NK cells localize in the sinusoids around T and B-cell areas, a location reminiscent of that in spleen where NK cells are found in the red pulp surrounding the white pulp. One possibility is that this area is reached by default, in the absence of CCR7 expression. Consistent with this model, human LN CD56 bright NK cells that do express CCR7 are localized, at least in part, in the T-cell cortex (73) . Recently, it was shown that CCR7 is induced on CD56 dim cells by IL-18 in vitro (74) , suggesting that under certain conditions, these cells could also traffic to LN.

Transfer experiments have shown that peripheral NK cells may also return to the BM. Central memory T cells preferentially home in this tissue by a mechanism that depends both on CXCL12 (CXCR4 ligand) and on E/P/L selectins (75) . Whether this is also the case for NK cells requires further investigation.

The distribution of NK cell subsets in the blood, spleen, liver, and lung is very similar, with a majority of CD27 dull NK cells. S1P 5 deficiency affects NK cells from these compartments in the same way (113) . This finding suggests, after their S1P 5 -dependent export to the periphery, that NK cells are carried by the blood flow in a S1P 5 -independent manner (Fig. 6) . A fraction of CD11b dull NK cells expressing CXCR6 is enriched in the liver. Similar to what was shown for NKT cells, these CXCR6 NK cells could patrol hepatic sinusoids through the interaction of CXCR6 with endothelium-bound CXCL16 (58) .

Upon inflammation, NK mouse cells may be recruited in various organs such as the LN, lung, liver, or central nervous system (CNS), and can then extravasate in the parenchyma or cavities (6) . The migration of leukocytes from the vascular lumen to tissues depends on a series of sequential molecular interactions between leukocytes and endothelial cells, involving selectins, integrins, and chemokine receptors.

In the mouse, L-selectin and P-selectin glycoprotein ligand-1 (PSGL-1) are expressed at similar levels on NK cell subsets ( Table  1) . L-selectin is required for mouse NK cell homing and recruitment to the LN (72). In human, CD56 bright but not mature CD56 dim CD16 1 NK cells also express L-selectin (71, 76) . Sialyl stage-specific embryonic antigen 1 and an uncharacterized sLe x -bearing receptor may serve as E-selectin ligands (77, 78) . Although PSGL-1 is expressed on freshly isolated human NK cells, only a minor population of NK cells binds P-selectin-immunoglobulin (Ig) (78, 79) . Human NK cell differentiation is accompanied by the cell surface expression of a mucin-like glycoprotein bearing an NK cellrestricted keratan sulfate-related lactosamine, the PEN5 epitope (80) . The PEN5 carbohydrate decorates PSGL-1, creating a unique binding site for L-selectin, which is independent of PSGL-1 tyrosine sulfation (76) . By analogy to the ability of rolling neutrophils to capture free-flowing neutrophils in a PSGL-1:L-selectin-dependent manner (81), the PEN5 epitope Fig. 6 . Model of mouse natural killer (NK) cell circulation at steady state. NK cells develop mostly in the bone marrow (BM) and, for the CD127 1 fraction, also in lymph node (LN) and thymus. NK cells mature from the CD11b dull stage to the double positive CD11b high CD27 high (DP) and further to the CD27 dull stage in all organs, starting in the BM (vertical dotted arrows). Upon maturation, they acquire S1P 5 expression and exit the BM in a S1P 5 -dependent manner. In this model, the more NK cells express S1P 5 , the more they exit the BM. Once in the periphery, they may return to BM and LN, through a CD62L-dependent mechanism for the LN. might allow NK cells to interact with other L-selectin 1 leukocytes (e.g. neutrophils, monocytes, or T/B lymphocytes) attached to the inflammatory endothelium to amplify the immune response.

The role of chemokine receptors in mouse NK cell recruitment to inflammatory sites has been studied using knockout strains and blocking antibodies (25, (64) (65) (66) (67) (82) (83) (84) (85) (86) (87) (88) (89) (90) (91) (92) . In humans, the expression of chemokines and their receptors at inflammatory sites has also provided some information (20, 57, 74, (93) (94) (95) (96) ( Table 2) .

Four receptors appear to play a key role in mouse NK cell recruitment following an inflammatory stimulus: CCR2, CCR5, CXCR3, and CX 3 CR1. These receptors allow NK cells to respond to a large array of inflammatory chemokines such as CCL2, CCL3, CCL5, CCL7, CCL8, CCL9, CCL11, CCL13, CXCL9-11 and CX3CL1. This broad responsiveness could warrant NK cell recruitment in situations where limited sets of chemokines are expressed. Thus, NK cell recruitment in the same tissue can be mediated by different chemokine receptors. For example, human NK cell recruitment to the epithelia appears to be dependent on CCR2, CCR5, CXCR3, or ChemR23, depending on the inflammatory conditions (20, 57, 93) . Not only may NK cells respond to different chemokines, but it also seems that chemokines may act in concert to recruit them. CCR2 and CCR5 are both required for NK cell recruitment to the liver of mouse cytomegalovirus (MCMV)-infected mice (83, 89) . A similar phenomenon had been observed previously for monocytes (97) . Importantly, NK cell subsets could also be differentially recruited, depending on the stimulus. Indeed, CX 3 CR1 but not CXCR3 is required for NK cell recruitment in the CNS in a model of experimental autoimmune encephalomyelitis (67, 84) . Conversely, CXCR3 has a central role in NK cell recruitment to the inflammatory LN (87) . As CXCR3 and CX 3 CR1 are expressed in a quasimutually exclusive fashion on NK cell subsets (Fig. 5) , this finding suggests that different NK cell subsets may be independently recruited in distinct inflammatory settings. Such a division of labor has already been shown for other types of leukocytes, including monocytes (98) and memory CD8 1 T cells (99) . Besides chemokines, NK cells have been shown to respond to various other chemotactic compounds that are either induced or augmented upon inflammation. These include lysophosphatidic acid (100) , N-formyl-methionylleucyl-phenylalanine (f-MLP) (101), leukotrienes (102), and C5a (103) . The roles of these inflammatory mediators and of their receptors in NK cell recruitment in vivo remain to be thoroughly investigated.

Integrins Upon activation by chemokines, NK cells interact firmly with the endothelium through integrins. The role of LFA1 (leukocyte function-associated antigen-1), as for other leukocytes, has been shown to be central in NK cell extravasation (104) . Interestingly, NK cells sequentially express different integrins over development and maturation (43) . To gain an insight into this phenomenon, we examined integrin expression at the mRNA level in sorted NK cells subsets, using microarrays. All NK cells express many transcripts of integrins involved in extravasation ( Table 1) . As reported previously, we found that CD49b and CD11b were acquired while CD51 was decreased upon NK cell maturation. Our data also show that CD11c and especially CD61 (b3 integrin) are decreased upon maturation. The significance of this observation is unclear, but different sets of integrins may contribute to the differential recruitment of NK cell subsets upon inflammation. Besides integrins, NK cell adhesion to the endothelium could also be mediated by CX 3 CR1. Indeed, it was reported previously that CX 3 CL1 mediates the rapid capture, integrin-independent firm adhesion, and activation of circulating leukocytes under flowthrough CX 3 CR1 (105).

NK cells migrate to the liver in response to a variety of stimuli, such as injection of maleic anhydride divinyl ether (MVE-2), Corynebacterium parvum (106), poly(I:C) (89, 107, 108) , MCMV (109), hepatitis B (110), or concanavalin-A (Con-A) (111) . Concomitant to the increase in liver NK cells, NK cell counts decrease in the spleen and BM, suggesting that these organs serve as reservoirs of NK cells in case of inflammation (65) . Various chemokine receptors may orchestrate this recruitment. CXCR3 is partly required in the mobilization of spleen NK cells, while CCR1 is required for the accumulation of NK cells in the liver (65) . To gain an insight into the mechanism of spleen NK cell mobilization, we performed immunofluorescence experiments on frozen sections of spleens obtained from mice intravenously injected with lipopoly- saccharide (LPS) or Con-A. A redistribution of splenic NK cells was observed in response to Con-A injection (Fig. 7) . NK cells appear to migrate from the red pulp to the marginal zone. This relocalization of NK cells was not observed when mice were treated with LPS, although this stimulus induces a massive redistribution of dendritic cells (Fig. 7A and data not shown). After Con-A injection, NK cells are thus found in close contact with marginal zone macrophages (Fig. 8) . It will be of interest to test whether CXCR3 is involved in this process. This phenomenon is transient, as 48 h after Con-A injection, NK cell distribution in the spleen is normal (Fig. 8) .

A massive recruitment of NK cells is observed in the draining LN in response to a footpad injection of Leishmania major (29), TLR 7/8 ligands, or LPS-activated dendritic cells (87) . This recruitment is dependent on CXCR3 (87) . CXCR3 ligands such as CXCL9 are expressed on the surface of inflammatory HEVs (112) . Under inflammatory conditions, most NK cells are recruited preferentially to the T-cell zone of the LN, near HEVs, in close proximity to dendritic cells (29) . NK cell recruitment is required for T-helper 1 cell polarization of naive T cells activated within the LN (87). In another system, it was found that CD62L was also required for the recruitment on the inflammatory LN in response to a subcutaneous injection of tumor cells (72) .

The precise knowledge of the anatomy of the immune system is obviously critical for our understanding of immunity. In contrast to T, B, and dendritic cells, the trafficking of NK cells in normal and disease conditions is poorly characterized.

Nevertheless, it appears that NK cells patrol lymphoid and non-lymphoid organs. At a steady state, NK cells are present at a high frequency in the circulation, ready to extravasate to tissues under inflammatory conditions. Besides the roles of S1P 5 and chemokine receptors, the set of molecules that govern NK cells trafficking in vivo remain to be identified. The dissection of the mechanisms that regulate NK cell migration may likely provide new perspectives for the manipulation of these cells for therapeutic purposes, as exemplified by the use of the S1P agonist, FTY720, as a T-and B-cell immunosuppressant.

control ConA 8h

ConA 48h Sialoadhesin NKp46 Fig. 8 . Kinetics of natural killer (NK) cell response to Con-A injection. C57BL/6 mice were treated with Con-A (300 mg) and sacrificed at the indicated times. Frozen sections of spleen were fixed with acetone and stained with anti-sialoadhesin and goat anti-NKp46 antibodies, as described in Fig. 2 . Sections were visualized by confocal microscopy.

What is a natural killer cell?

Interplay of natural killer cells and their receptors with the adaptive immune response

Ligands for natural killer cell receptors: redundancy or specificity

KIR: diverse, rapidly evolving receptors of innate and adaptive immunity

Natural killer cell signaling pathways

Biology of natural killer cells

Natural killer (NK) cell activity in the rat. I. Isolation and characterization of the effector cells

What does it take to make a natural killer

Preferential localization of effector memory cells in nonlymphoid tissue

Strange brew: T cells in the liver

Resident human hepatic lymphocytes are phenotypically different from circulating lymphocytes

The abundant NK cells in human secondary lymphoid tissues require activation to express killer cell Ig-like receptors and become cytolytic

Natural killer cells and pregnancy

Homing and function of human skin {gamma}{delta} T cells and NK cells: relevance for tumor surveillance

The HECA-452 epitope is highly expressed on lymph cells derived from human skin

Natural killer and dendritic cell contact in lesional atopic dermatitis skin -Malassezia-influenced cell interaction

T cell-and B cell-independent adaptive immunity mediated by natural killer cells

Natural killer and natural killer-T cells in psoriasis

Psoriasis is mediated by a cutaneous defect triggered by activated immunocytes: induction of psoriasis by cells with natural killer receptors

CD56brightCD16( À ) NK cells accumulate in psoriatic skin in response to CXCL10 and CCL5 and exacerbate skin inflammation

Intestinal intraepithelial lymphocytes contain a CD3 À CD71 subset expressing natural killer markers and a singular pattern of adhesion molecules

Human small-intestinal epithelium contains functional natural killer lymphocytes

Characteristics of natural killer cells in the murine intestinal epithelium and lamina propria

Natural killer activity of gut mucosal lymphoid cells in mice

Susceptibility of CCR5-deficient mice to genital herpes simplex virus type 2 is linked to NK cell mobilization

Interleukin-15 and Natural Killer and NKT Cells Play a Critical Role in Innate Protection against Genital Herpes Simplex Virus Type 2 Infection

NK and NKT cell-independent contribution of interleukin-15 to innate protection against mucosal viral infection

NK1.11 cells and murine cytomegalovirus infection: what happens in situ?

Natural killer cell behavior in lymph nodes revealed by static and realtime imaging

Analysis of in situ NK cell responses during viral infection

Immunodeficient mice have elevated numbers of NK cells in non-lymphoid tissues

NK cell trafficking and cytokine expression in splenic compartments after IFN induction and viral infection

Identification, activation, and selective in vivo ablation of mouse NK cells via NKp46

Natural killer cells and dendritic cells: rendezvous in abused tissues

Natural-killer cells and dendritic cells: ''l'union fait la force

Close encounters of different kinds: dendritic cells and NK cells take centre stage

Whatever turns you on: accessory-cell-dependent activation of NK cells by pathogens

The liver as an immunological organ

A human CD34(1) subset resides in lymph nodes and differentiates into CD56bright natural killer cells

A thymic pathway of mouse natural killer cell development characterized by expression of GATA-3 and CD127

Germ-line and rearranged Tcrd transcription distinguish bona fide NK cells and NK-like gammadelta T cells

TRAIL identifies immature natural killer cells in newborn mice and adult mouse liver

In vivo developmental stages in murine natural killer cell maturation

CD27 dissects mature NK cells into two subsets with distinct responsiveness and migratory capacity

Functional subsets of mouse natural killer cells

CD56brightCD16-killer Ig-like receptor-NK cells display longer telomeres and acquire features of CD56dim NK cells upon activation

Natural killer cell activity in the rat. V. The circulation patterns and tissue localization of peripheral blood large granular lymphocytes (LGL)

In vivo evidence for a dependence on interleukin 15 for survival of natural killer cells

In vivo survival and homeostatic proliferation of natural killer cells

IL-15 is an essential mediator of peripheral NK-cell homeostasis

Unique subpopulations of CD561 NK and NK-T peripheral blood lymphocytes identified by chemokine receptor expression repertoire

Identification and molecular characterization of fractalkine receptor CX3CR1, which mediates both leukocyte migration and adhesion

Human NK cells express CC chemokine receptors 4 and 8 and respond to thymus and activation-regulated chemokine, macrophage-derived chemokine

Expression and regulation of chemokine receptors in human natural killer cells

Differential chemokine responses and homing patterns of murine TCR alpha beta NKT cell subsets

Dual functions of fractalkine/CX3C ligand 1 in trafficking of perforin1/granzyme B1cytotoxic effector lymphocytes that are defined by CX3CR1 expression

The role of chemerin in the colocalization of NK and dendritic cell subsets into inflamed tissues

Intravascular immune surveillance by CXCR61 NKT cells patrolling liver sinusoids

Analysis of fractalkine receptor CX(3)CR1 function by targeted deletion and green fluorescent protein reporter gene insertion

Novel insights on human NK cells' immunological modalities revealed by gene expression profiling

Gene and protein characteristics reflect functional diversity of CD56dim and CD56bright NK cells

Involvement of CXCR4 and IL-2 in the homing and retention of human NK and NK T cells to the bone marrow and spleen of NOD/SCID mice

Enhanced unique pattern of hematopoietic cell mobilization induced by the CXCR4 antagonist 4F-benzoyl-TN14003

Regulation of pulmonary fibrosis by chemokine receptor CXCR3

IFN-gamma acts on T cells to induce NK cell mobilization and accumulation in target organs

CXCR3 and its ligands participate in the host response to Bordetella bronchiseptica infection of the mouse respiratory tract but are not required for clearance of bacteria from the lung

Severe disease, unaltered leukocyte migration, and reduced IFNgamma production in CXCR3 À/À mice with experimental autoimmune encephalomyelitis

Chemokines, sphingosine-1-phosphate, and cell migration in secondary lymphoid organs

Regulation of immunity by lysosphingolipids and their G proteincoupled receptors

Mature natural killer cell and lymphoid tissueinducing cell development requires Id2-mediated suppression of E protein activity

Differential expression and function of L-selectin on CD56bright and CD56dim natural killer cell subsets

Suppression of tumor formation in lymph nodes by L-selectin-mediated natural killer cell recruitment

Distinct roles of IL-12 and IL-15 in human natural killer cell activation by dendritic cells from secondary lymphoid organs

IL-18-induced CD831CCR71 NK helper cells

Bone marrow is a major reservoir and site of recruitment for central memory CD81 T cells

Modification of P-selectin glycoprotein ligand-1 with a natural killer cell-restricted sulfated lactosamine creates an alternate ligand for L-selectin

Differentiation-dependent expression of sialyl stage-specific embryonic antigen-1 and I-antigens on human lymphoid cells and its implications for carbohydrate-mediated adhesion to vascular endothelium

IL-12 promotes the adhesion of NK cells to endothelial selectins under flow conditions

A novel P-selectin glycoprotein ligand-1 monoclonal antibody recognizes an epitope within the tyrosine sulfate motif of human PSGL-1 and blocks recognition of both P-and L-selectin

Developmental regulation of a mucinlike glycoprotein selectively expressed on natural killer cells

Neutrophil-neutrophil interactions under hydrodynamic shear stress involve L-selectin and PSGL-1. A mechanism that amplifies initial leukocyte accumulation of P-selectin in vitro

Dengue virus induces expression of CXC chemokine ligand 10/ IFN-gamma-inducible protein 10, which competitively inhibits viral binding to cell surface heparan sulfate

Monocyte chemoattractant protein-1 and CCR2 interactions are required for IFN-alpha/beta-induced inflammatory responses and antiviral defense in liver

The neuronal chemokine CX3CL1/fractalkine selectively recruits NK cells that modify experimental autoimmune encephalomyelitis within the central nervous system

CCR5 is essential for NK cell trafficking and host survival following Toxoplasma gondii infection

Fractalkine mediates natural killer-dependent antitumor responses in vivo

Induced recruitment of NK cells to lymph nodes provides IFN-gamma for T(H)1 priming

Chemokine-mediated recruitment of NK cells is a critical host defense mechanism in invasive aspergillosis

Early murine cytomegalovirus (MCMV) infection induces liver natural killer (NK) cell inflammation and protection through macrophage inflammatory protein 1alpha (MIP-1alpha)-dependent pathways

T cell antiviral effector function is not dependent on CXCL10 following murine coronavirus infection

Chemokines in hepatitis C virus infection: pathogenesis, prognosis and therapeutics

Defective antitumor responses in CX3CR1-deficient mice

Functional aberrant expression of CCR2 receptor on chronically activated NK cells in patients with TAP-2 deficiency

CXCL12 expression by invasive trophoblasts induces the specific migration of CD16 À human natural killer cells

Involvement of the fractalkine pathway in the pathogenesis of childhood hemolytic uremic syndrome

Recruitment of uterine NK cells: induction of CXC chemokine ligands 10 and 11 in human endometrium by estradiol and progesterone

Monocyte subsets differentially employ CCR2, CCR5, and CX3CR1 to accumulate within atherosclerotic plaques

Migratory fate and differentiation of blood monocyte subsets

Two subsets of memory T lymphocytes with distinct homing potentials and effector functions

Lysophosphatidic acid induces human natural killer cell chemotaxis and intracellular calcium mobilization

Chemotaxis of large granular lymphocytes

An improved in vitro assay to quantitate chemotaxis of rat peripheral blood large granular lymphocytes (LGL)

In vitro migration of human large granular lymphocytes

Migration of natural killer cells across endothelial cell monolayers

Fractalkine and CX3CR1 mediate a novel mechanism of leukocyte capture, firm adhesion, and activation under physiologic flow

Augmentation of organassociated natural killer activity by biological response modifiers. Isolation and characterization of large granular lymphocytes from the liver

Increase in liver-associated natural killer activity by polyribonucleotides

TLR3 ligand-induced accumulation of activated splenic natural killer cells into liver

Natural killer cells in antiviral defense: function and regulation by innate cytokines

Activation and function of hepatic NK cells in hepatitis B infection: an underinvestigated innate immune response

Critical contribution of liver natural killer T cells to a murine model of hepatitis

L-selectin-negative CCR7( À ) effector and memory CD8(1) T cells enter reactive lymph nodes and kill dendritic cells

Natural cell trafficking in vivo requires a dedicated sphingosine 1-phosphate receptor